IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100IPHA_logo_main_version_h100
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Annual Conference 2026
    • All other events
  • Publications
    • 2026
      • EFPIA Patients W.A.I.T. Indicator 2025 Survey
      • CRA EFPIA – European Access Hurdles Portal – Final Report
      • The Pharmaceutical Sector in Ireland: by Goodbody
      • Irish women’s health in their own words: by Olytico
      • IPHA Framework Agreement 2026-2029
    • 2025
      • Industry’s Role in Shaping Ireland’s Life Science Strategy
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Submissions
    • 2025
      • IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
      • IPHA Life Science Strategy Submission Dec 25
      • IPHA Response LSS Consultation final 25
      • RD Incentives Consulation_Final 19 May 25
    • 2024
      • IPHA Submission National Rare Disease Strategy 2024
    • 2023
      • Expert Taskforce Submission September 2023 letter
      • Sinn Fein consultation paper Dec 23
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • #InnovateForLife
  • News
  • Events
    • IPHA Forum
    • IPHA Annual Conference 2026
    • All other events
  • Publications
    • 2026
      • EFPIA Patients W.A.I.T. Indicator 2025 Survey
      • CRA EFPIA – European Access Hurdles Portal – Final Report
      • The Pharmaceutical Sector in Ireland: by Goodbody
      • Irish women’s health in their own words: by Olytico
      • IPHA Framework Agreement 2026-2029
    • 2025
      • Industry’s Role in Shaping Ireland’s Life Science Strategy
      • EFPIA Patients Wait Indicator 2024
      • IPHA Position Paper on Fairer and Faster Access to Medicine
    • 2024
      • EFPIA Patient WAIT Indicator Survey
      • Clinical Trials Agreement
      • Making Ireland a European Leader in Clinical Research
    • 2023
      • Achieving Universal Access to New Medicines for Irish Patients
      • Oireachtas briefing
      • IPHA Policy on Supply Outside Reimbursement Final
      • IPHA Self-Care Infographic
    • 2022
      • IPHA reimbursement timelines analysis 2022
      • Factors Affecting the Location of Biopharmaceutical Investments and Implications for European Policy Priorities
      • IHE Cancer Care Comparator Study
      • White Paper on Enterprise
    • 2021
      • Clinical Trials Survey
      • Cell and Gene Pathfinder Study
      • IPHA Codes of Practice
      • Agreement 2021
    • Pre 2020
      • BioPharma Ambition
      • Manifesto for Better Health
      • Innovation and the IP Framework
      • Self-Care: Taking Charge of Your Health
      • Vaccines For Life
      • Perspectives on Ireland’s Medicines Future
  • Submissions
    • 2025
      • IPHA Submission to Department of Foreign Affairs and Trade EU Presidency 2026
      • IPHA Life Science Strategy Submission Dec 25
      • IPHA Response LSS Consultation final 25
      • RD Incentives Consulation_Final 19 May 25
    • 2024
      • IPHA Submission National Rare Disease Strategy 2024
    • 2023
      • Expert Taskforce Submission September 2023 letter
      • Sinn Fein consultation paper Dec 23
  • Code
    • Codes of Practice
    • Transfers of Value
    • Mandatory notification regarding Advisory Board Meetings
    • IPHA Code Training
    • Complaints
  • Clinical & Regulatory
    • Regulation for Innovation
    • Clinical Trials
    • Medicine Safety
    • Regulatory Science Ireland
    • Counterfeit Medicines
  • Self-Care
  • About
    • Members
    • Board of Directors
    • Media Queries
    • Our Team
    • Affiliates Programme
    • Job Opportunities
  • Home
  • About Us
  • Contact Us

Jen and Leona’s stories

  • Home
  • News
  • Innovation
  • #InnovateForLife
  • 2024
  • Jen and Leona’s stories

Jen and Leona’s stories.

Telling their stories are Jen and Leona who, because of advanced migraine medicines, have both been able to experience more of life’s important little moments.

Listen to Podcast:

Choose your platform below:

Watch our Podcast:

In the podcast, they openly share their experiences of how migraine once impacted their lives – on being a mother, on their careers, on their relationships – and how transformational their treatment has been.

Previous #InnovateForLife Campaigns

Jen and Leona’s stories

Because of new medicines – Mary’s story

Because of new medicines – Carmel’s story

Because of new cancer medicines – Patrick’s story

Innovate Today, Transform Tomorrow

A future where cancer isn’t just treated, but cured

Ending HIV for everyone, everywhere

Revolutionising drug discovery

Six Degrees of Innovation

How science is transforming the lives of HIV patients

Navigating precision oncology

Innovation in the battle against CLL

Sizing the therapeutic potential of mRNA

Advancing the Fight Against Obesity

Breakthrough Science for Better Health

Moving Towards Better Heart Health

Pioneering in Dermatology by Looking Beyond Today

Pushing the Boundaries of Alzheimer’s Research

Counting on a Cancer Breakthrough

Innovation in the Rural Economy

The Impact of Investment

The Promise of Science

Caroline Irwin

Cork Harbour

Dr Jennifer McAuliffe and Ellen Duggan

Dr Orla Cunningham

Eoghan Quinn

Westport

Terms and Conditions    |    Privacy Statement   |   Sitemap    |    Cookies


Registered Number: 254776    |    Registered Address: 7 Clanwilliam Terrace, Dublin 2, D02 CC64 Ireland   |  Email: info@ipha.ie

© 2024 IPHA